NOTE from DearMYRTLE: The following just came across the news wires about Ancestry.com. Please direct all inquiries to support@ancestry.com.
PROVO, Utah, May 16, 2012 (GLOBE NEWSWIRE) -- Ancestry.com Inc. (Nasdaq:ACOM - News), the world's largest online family history resource, today announced that renowned genomics expert Dr. Paul R. Billings has been appointed to the Company's Board of Directors, increasing the Board's size to nine members. Billings was also appointed a member of the Company's Audit Committee.
"Dr. Billings makes a great addition to our Board at a time when our
focus on genetic genealogy is just at its beginning stages," said Tim
Sullivan, President and CEO of Ancestry.com. "Paul's addition shows our
company's reinforced commitment to the science of DNA that we are
convinced will provide a new way for customers to make amazing
discoveries that they can share with family and friends."
A board certified internist and clinical geneticist, Billings serves as Chief Medical Officer at Life Technologies Corporation
and has extensive expertise and clinical experience in the areas of
genomics and molecular medicine. Prior to joining Life Technologies,
Billings was the Chief Executive Officer of CELLective Dx Corporation,
prior to which he was Senior Vice President of Laboratory Corporation of America Holdings.
He is the author of nearly 200 publications and books on genomic
medicine and holds a bachelor's degree from the University of California
at San Diego and an M.D. and Ph.D. in Immunology from Harvard
University.
About Ancestry.com
Ancestry.com Inc. (Nasdaq:ACOM - News)
is the world's largest online family history resource, with 1.9 million
paying subscribers. More than 10 billion records have been added to the
site in the past 15 years. Ancestry users have created more than 34
million family trees
containing approximately 4 billion profiles. In addition to its
flagship site, Ancestry.com offers several localized Web sites designed
to empower people to discover, preserve and share their family history.
No comments:
Post a Comment